DR. GERMAINE N ROWE MD NPI 1710960372

NPI Details

DR. Germaine N Rowe, MD is a pain medicine physical medicine rehabilitation in Staten Island, NY with 31 years of experience. The provider is a physician who provides a high level of care, either as a primary physician or consultant, for patients experiencing problems with acute, chronic or cancer pain in both hospital and ambulatory settings. Patient care needs may also be coordinated with other specialists. DR. Germaine N Rowe, MD NPI is 1710960372. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: STATE UNIVERSITY OF NEW YORK AT BUFFALO SCHOOL OF MEDICINE
Graduation Year:1995

The provider's business location address is:

1099 TARGEE ST
STATEN ISLAND, NY
ZIP 10304-310
Phone: (718) 448-3210
Fax: (718) 815-3379

The NPI 1710960372 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, midazolam hydrochloride, per 1 mg (HCPCS:J2250)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Testing for presence of drug, read by direct observation (HCPCS:80305)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Needle measurement of electrical activity in arm or leg muscles, complete study (HCPCS:95886)
• Injection, fentanyl citrate, 0.1 mg (HCPCS:J3010)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0482)
• Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml (HCPCS:Q9966)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Injection of substance into lower spine canal using imaging guidance (HCPCS:62323)
• Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level (HCPCS:64483)
• X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
• Nerve conduction, 9-10 studies (HCPCS:95911)
• Electrocardiogram (ecg) 1 to 3 leads with review by physician (HCPCS:93040)
• Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint (HCPCS:64636)
• Injection of substance into middle or upper spine canal using imaging guidance (HCPCS:62321)
• Nerve conduction, 11-12 studies (HCPCS:95912)
• Fluoroscopic guidance for needle placement (HCPCS:77002)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint (HCPCS:64635)
• Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes (HCPCS:99152)
• X-ray of joint between lower spine and hip bone, 1-2 views (HCPCS:72200)

The enumeration date for this NPI number is 11/28/2005 and was last updated on 2/12/2018.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.